Incidence of Hypophosphatemia After Treatment With Iron Isomaltoside/Ferric Derisomaltose vs Ferric Carboxymaltose in Subjects With Iron Deficiency Anaemia
Clinical trial NCT03238911 · COMPLETED
Trial details
- NCT number
- NCT03238911
- Sponsor
- Pharmacosmos A/S
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-10-24
- Primary completion
- 2018-06-19
- Enrollment
- 123
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.